Holen Sie sich die Stockscreener-App
1.0047
5.66%
-0.0553
Schlusskurs vom Vortag:
$1.06
Offen:
$1.07
24-Stunden-Volumen:
228.53K
Relative Volume:
0.50
Marktkapitalisierung:
$5.42M
Einnahmen:
$895.50K
Nettoeinkommen (Verlust:
$-26.30M
KGV:
-0.0153
EPS:
-65.5728
Netto-Cashflow:
$-23.84M
1W Leistung:
-30.07%
1M Leistung:
-35.48%
6M Leistung:
-52.15%
1J Leistung:
-88.23%
1-Tages-Spanne:
$0.92
$1.09
1-Wochen-Bereich:
$0.92
$1.40
52-Wochen-Spanne:
$0.92
$10.56
Mainz Biomed N V Stock (MYNZ) Company Profile
Firmenname
Mainz Biomed N V
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie MYNZ mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MYNZ
Mainz Biomed N V
|
1.0019 | 5.74M | 895.50K | -26.30M | -23.84M | -65.57 |
|
TMO
Thermo Fisher Scientific Inc
|
583.83 | 215.18B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
226.28 | 156.94B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
725.63 | 55.05B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
150.08 | 41.12B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
224.06 | 36.97B | 15.90B | 1.28B | 2.21B | 7.2842 |
Mainz Biomed N V Stock (MYNZ) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-14 | Eingeleitet | Maxim Group | Buy |
| 2024-11-25 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2023-11-21 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2022-06-21 | Eingeleitet | H.C. Wainwright | Buy |
Mainz Biomed N V Aktie (MYNZ) Neueste Nachrichten
Will Mainz Biomed N.V. stock see insider buyingJuly 2025 Closing Moves & Daily Profit Maximizing Trade Tips - newser.com
Is Mainz Biomed N.V. stock positioned well for digital economy2025 Bull vs Bear & Reliable Price Breakout Signals - newser.com
Is Mainz Biomed N.V. (4TO) stock attractive for dividend growth - newser.com
What’s the recovery path for long term holders of Mainz Biomed N.V.Earnings Growth Report & Stepwise Swing Trade Plans - newser.com
Can Mainz Biomed N.V. stock continue upward trend2025 Biggest Moves & Trade Opportunity Analysis Reports - newser.com
What margin trends mean for Mainz Biomed N.V. stockJuly 2025 Reactions & Breakout Confirmation Trade Signals - newser.com
Why Mainz Biomed N.V. (4TO) stock attracts wealthy investorsJuly 2025 Fed Impact & High Accuracy Investment Signals - newser.com
Is a relief rally coming for Mainz Biomed N.V. holdersInflation Watch & Verified Technical Signals - newser.com
Will Mainz Biomed N.V. outperform the marketBond Market & Short-Term Trading Opportunity Alerts - newser.com
How Mainz Biomed N.V. (4TO) stock performs in easing cycles - newser.com
Mainz Biomed and OncoVanguard8 Enter into Agreement to bring ColoAlert to South America - The Manila Times
Mainz Biomed (NASDAQ: MYNZ) signs ColoAlert MOU for Peru, Colombia and Ecuador - Stock Titan
Can Mainz Biomed N.V. stock deliver strong Q4 earnings2025 Key Lessons & Breakout Confirmation Alerts - newser.com
Mainz Biomed N.V (MYNZ) Performance and Fundamentals Dashboard tells a completely different story - Setenews
What to do if you’re stuck in Mainz Biomed N.V.Weekly Trend Summary & High Return Trade Opportunity Guides - newser.com
Will Mainz Biomed N.V. (4TO) stock return to pre crash levelsPortfolio Risk Summary & Real-Time Sentiment Analysis - newser.com
Is Mainz Biomed N.V. stock a safe investment in uncertain marketsInsider Buying & Daily Entry Point Trade Alerts - newser.com
Will Mainz Biomed N.V. stock remain a Wall Street favorite2025 Market Overview & Verified Swing Trading Watchlists - newser.com
Key resistance and support levels for Mainz Biomed N.V.Wall Street Watch & Daily Profit Focused Screening - newser.com
Will Mainz Biomed N.V. (4TO) stock rise with strong economyDay Trade & AI Enhanced Trading Signals - newser.com
Is Mainz Biomed N.V. (4TO) stock good for wealth creationJuly 2025 Fed Impact & Weekly High Conviction Trade Ideas - Fundação Cultural do Pará
How Mainz Biomed N.V. stock valuations compare to rivals2025 Price Momentum & Weekly Momentum Stock Picks - Fundação Cultural do Pará
Is Mainz Biomed N.V. stock a defensive play in 20252025 Investor Takeaways & Comprehensive Market Scan Reports - Fundação Cultural do Pará
Finanzdaten der Mainz Biomed N V-Aktie (MYNZ)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.13%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):